Niverco Biomedical is categorized under Medical Equipment Repairs in Houston, TX and active since 1979.
Niverco Biomedical was established in 1979, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Equipment Repairs business, which does work in the B2C market, and is classified as a Medical Equipment Repairs, under code number 8112191 by the NAICS.
If you are seeking more information, feel free to contact Dale Niver, Owner at the company’s single location by writing to 8911 Interchange Drive, Houston, Texas TX 77054 or by phoning (713) 528-6023. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Niverco Biomedical |
| Contact Person: | Dale Niver, Owner |
| Address: | 8911 Interchange Drive, Houston, Texas 77054 |
| Phone Number: | (713) 528-6023 |
| Website Address: | niverco.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1979 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Equipment Repairs |
| SIC Code: | 7699 |
| NAICS Code: | 8112191 |
| Share This Business: |
Niverco Biomedical was started in 1979 to provide professional Medical Equipment Repairs under the SIC code 7699 and NAICS code 8112191. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Dale Niver, Owner for inquiries that concern Niverco Biomedical by calling the company number (713) 528-6023, as your correspondence is most welcome. Additionally, the physical location of the single location of Niverco Biomedical can be found at the coordinates 29.6741,-95.41458 as well as the street address 8911 Interchange Drive in Houston, Texas 77054.
For its online presence, you may visit Niverco Biomedical’s website at niverco.com and engage with its social media outlets through on Twitter and on Facebook.